inhibition of FAK signaling inhibits hypertrophic scar formation through this mechanism. 10, 11 Reducing the mechanical force on a wound by reducing the need to contract results in less hypertrophic scarring. 12 Part of the goal of skin grafting is to reduce this mechanical load to allow for better wound healing. Wound inflammation, in general, through either tension, infection, or prolonged healing by second intention, has been shown to predispose to hypertrophic scar formation. 13, 14 A possible benefit of the "graft back" procedure is a reduction in all of these causes.
In addition to reducing the incidence of hypertrophic scarring, the type of dressing/coverage of a donor site can affect infection rate. 15 There are obvious risks/disadvantages to leaving a donor site open, which is why many clinicians prefer the application of a dressing or cover to promote healing and reduce infection risk. Although many studies were small, one review of several studies comparing infection rates quoted the average infection rate of an exposed donor site at approximately 5%. 15 The infection rate Figure 1 . Schematic demonstrating where grafts are taken on the thigh of a patient who received the "graft back" procedure. The initial donor site is identified in blue, and the "graft back" donor site is identified in red. In this photograph, the second graft (red) has been meshed and placed over both donor sites. with a dressing/cover can vary widely with much higher or lower infection rates than exposed wounds depending on the material used.
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SKIN GRAFTING FOR DONOR SITE COVERAGE
The technique and mechanism of skin grafting using a meshed STSG at the site of injury is well established. Tanner et al 18 first described these methods, and they have since become an integral aspect of grafting and the care of grafted wounds. Meshing a STSG allows for a limited surface area to be grafted and expanded to cover much larger wound areas than the donor site. It allows for rapid epithelialization of the wound and reduces fluid accumulation underneath the graft, enhancing the graft take and healing. 18 Given the success of meshed STSG on graft sites and the relative lack of guidelines for donor site management, we sought a new method that combines these principles. In this article, we describe a method of STSG donor site management involving an identical graft harvested immediately adjacent to the primary graft donor site, meshing the graft 4:1, and placing it over both donor sites after extensive meshing to facilitate reepithelialization. This method might result in improved wound healing on the donor site with faster healing time, improved cosmetic outcome, and rapid epithelialization, although prospective studies are needed before definitive recommendations can be made. We believe that this method has particular value in patients in whom wound healing is likely to be a concern and ideally will prevent wound healing complications postoperatively.
METHODS
We retrospectively looked at 17 patients who had undergone this graft back procedure to evaluate the efficacy of this new method of donor site grafting. Many of the patients selected for this procedure were burn-injured patients with increased risk for poor wound healing of the donor site. These risk factors include age, diabetes, peripheral vascular disease, immunosuppression, calciphylaxis, malignancy, mixed connective tissue disorder, pain control concerns, or smoking. All patients were patients at level 1 trauma centers, and many had significant comorbidities in addition to age. These constellations of comorbidities we felt put these patients at an extreme risk for wound healing difficulties, which warranted this procedure.
The mechanism of donor site grafting in these patients of high risk was as follows: at the time of the grafting, a STSG is harvested in the usual manner, most frequently from the upper thigh, although any area of viable tissue is acceptable. The first STSG is then placed in its desired location for wound coverage. Attention is then turned to the donor site, where another, identically sized, STSG is taken immediately adjacent to the primary donor site. This STSG is harvested and then meshed at a 4:1 ratio.
The graft is then placed over both STSG donor sites, covering the wound entirely ( Figure 1) . The graft is then affixed with interrupted 5-0 chromic sutures in the corners followed by spray thrombin/fibrinogen and then covered with a mepilex dressing for 5 to 7 days. After the procedure, patients were analyzed for wound healing complications. We defined complications as graft failure, hematoma, or infection at the donor site.
RESULTS
We performed a graft back on 17 patients. The average age of our cohort was 65 years with an average of four comorbidities ( Table 1 ). All of the donor sites that were grafted back were on the thigh. Of the 17 patients selected to undergo this procedure, none have had any reported wound healing complications, including graft failure, hematoma, or infection. Early grafting has a somewhat meshed appearance and only requires a few tacking sutures or staples ( Figure 2) . Eventually, this meshed pattern improves significantly as the interstices fill in (Figure 3) . One patient had postoperative bleeding from the donor site that required bedside intervention. Examination of the grafts postoperatively shows normal wound healing and graft acceptance. Histologic examination of the graft donor sites compared with native skin has demonstrated complete epithelialization of the wound with good result (Figure 4) . Most notably, there is relatively equal thickness of epithelium in both specimens. Postoperatively, the graft heals well with acceptable cosmetic outcome (Figures 5 and 6 ).
DISCUSSION
There are many different options for management of the STSG donor site ranging from exposure to synthetic material or dressings, many of which are valid.
The numerous options available for management allow each surgeon to have individual preferences and styles of how to manage the skin graft donor site. The overarching goal of the management of the STSG donor site is prevention of infection, minimize pain, and to preserve aesthetic appearance as much as possible. This is achieved by providing a moist wound environment, preventing disruption to allow for reepithelialization, and to ensure healing in the shortest period of time possible. Numerous comparisons have been made among various dressings and treatment options to evaluate these outcomes, but given the sheer number of dressing and treatment possibilities, it is difficult to compare all of them in a single study. 5 The volume of different types of studies also makes establishing a baseline complication rate for donor site management impossible. Some studies comparing various dressings suggest options such as duoderm and Xeroform are among the best dressing options. Despite the number of studies regarding wound dressings, it is difficult to find studies discussing autologous grafts for management of donor sites. This is important given the potential for high donor site complication rates, ranging from 6 to 100% depending on the type of donor site. [24] [25] [26] [27] One study of 20 patients compared a living skin equivalent to autograft and polyurethane occlusive dressing for management of the STSG donor site and showed a living skin equivalent and autograft to be similar, and both superior to the polyurethane occlusive dressing. 28 Other case reports have reported various methods of autologous grafting of the donor site, without reporting complication rates or other statistics. 1, 29 One case study describing an autologous grafting method used in 46 patients reported no complications in their cohort. 3 However, more rigorous studies comparing autografting to donor site dressings are warranted given the theoretical benefits in certain situations of autologous grafting vs wound dressings related to wound healing. Additionally, variations of autografting the donor site have been reported, and it would be clinically useful to the practicing surgeon to know the comparisons of these treatment options to popular dressings. 1, 3, 30 The method of grafting back the donor site presented in this article is a viable one with good results given that no complications have been reported in the patients receiving this treatment thus far and have had acceptable cosmetic and functional outcomes. We recommend adding this procedure to the trauma surgeon's repertoire of skin graft donor site management for use in patients likely to have extreme wound healing difficulty. More studies are necessary to further evaluate the absolute complication rates and compare with dressing options, but with our initial sample, the complication rate seems to be lower than other methods of donor site management available. Comparison with a cohort of similarly aged and comorbid patients would strengthen our recommendation for this method of donor site management and is an area of future research. It is important to consider the utility of this method, as many of our patients with extreme comorbidities were able to heal well with this method.
19-23
The managing surgeon must also balance the considerations of additional grafting and wound creation with the perceived benefits of autologous donor site coverage to facilitate healing. Other methods of grafting, such as harvesting a thinner graft or grafting from an area with greater dermal thickness, are also valid considerations; however, our method presents an opportunity to consolidate both donor sites and provide autologous coverage via a single graft.
In patients with sufficient intact soft tissue to permit this method, it seems to be a reasonable consideration for management of a STSG donor site.
CONCLUSIONS
In this study, we introduce a method to promote wound healing in STSG by including a second graft covering the donor site using a "graft back" method. In patients with increased risk for poor wound healing who undergo STSG for burns or graft-requiring injury, this approach should be considered. Further study is warranted to evaluate additional strengths and benefits of the back graft. However, in our experience, it results in improved healing and cosmetic appearance of the donor site without an increase in complications.
